GROUP ONE TRADING, L.P. - REVANCE THERAPEUTICS INC ownership

REVANCE THERAPEUTICS INC's ticker is and the CUSIP is 761330959. A total of 3 filers reported holding REVANCE THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GROUP ONE TRADING, L.P. ownership history of REVANCE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$3,835,568
-47.1%
334,400
+16.6%
0.01%
-43.5%
Q2 2023$7,256,377
-8.7%
286,700
+16.2%
0.02%
-20.7%
Q1 2023$7,946,207
+133.3%
246,700
+33.7%
0.03%
+262.5%
Q4 2022$3,405,870
+37.4%
184,500
+101.0%
0.01%
+60.0%
Q3 2022$2,479,000
+55.3%
91,800
-20.5%
0.01%
+66.7%
Q2 2022$1,596,000
+476.2%
115,500
+713.4%
0.00%
Q1 2022$277,000
+2418.2%
14,200
+3450.0%
0.00%
Q3 2021$11,000
-8.3%
4000.0%0.00%
Q2 2021$12,000
-87.8%
400
-88.6%
0.00%
Q1 2021$98,000
-44.3%
3,500
-51.4%
0.00%
-100.0%
Q2 2020$176,000
+60.0%
7,200
-2.7%
0.00%0.0%
Q1 2020$110,000
+400.0%
7,400
+722.2%
0.00%
Q3 2018$22,000
-26.7%
900
-18.2%
0.00%
Q2 2018$30,000
+400.0%
1,100
+450.0%
0.00%
Q1 2018$6,000
-99.0%
200
-98.9%
0.00%
-100.0%
Q4 2017$626,000
+7725.0%
17,500
+3400.0%
0.00%
Q3 2016$8,000
-73.3%
500
-77.3%
0.00%
Q2 2016$30,000
-72.2%
2,200
-64.5%
0.00%
-100.0%
Q1 2016$108,000
-41.3%
6,200
+14.8%
0.00%0.0%
Q4 2015$184,000
+4500.0%
5,400
+2600.0%
0.00%
Q1 2015$4,000
-91.3%
200
-92.6%
0.00%
-100.0%
Q4 2014$46,0002,7000.00%
Other shareholders
REVANCE THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Sea Otter Advisors LLC 5,000$57,3500.03%
GROUP ONE TRADING, L.P. 334,400$3,835,5680.01%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
SIMPLEX TRADING, LLC 42,000$4810.00%
JPMORGAN CHASE & CO 15,700$180,0790.00%
JANE STREET GROUP, LLC 64,900$744,4030.00%
View complete list of REVANCE THERAPEUTICS INC shareholders